tiprankstipranks
Trending News
More News >

Imunon Announces Private Placement Agreement with Investors

Story Highlights
Imunon Announces Private Placement Agreement with Investors

Confident Investing Starts Here:

Imunon ( (IMNN) ) has shared an announcement.

On May 23, 2025, Imunon, Inc. announced a securities purchase agreement with institutional and accredited investors for a private placement of common stock and warrants, expected to close around May 27, 2025. The company anticipates gross proceeds of $3.25 million, with a potential additional $6.5 million if all warrants are exercised. The proceeds will be used for working capital and general corporate purposes. The company has agreed to file a registration statement with the SEC and plans to hold a stockholder meeting to obtain necessary approvals for the warrants. H.C. Wainwright & Co. is the lead placement agent for this transaction.

The most recent analyst rating on (IMNN) stock is a Buy with a $14.00 price target. To see the full list of analyst forecasts on Imunon stock, see the IMNN Stock Forecast page.

Spark’s Take on IMNN Stock

According to Spark, TipRanks’ AI Analyst, IMNN is a Neutral.

Imunon’s financial instability, characterized by negative revenue and cash flow metrics, significantly impacts its overall stock score. Technical indicators suggest caution, with bearish trends and lack of momentum. Though the recent earnings call highlights promising clinical progress, concerns about cash runway and funding remain. Valuation metrics further reflect the stock’s risky profile, with a negative P/E ratio and no dividend yield.

To see Spark’s full report on IMNN stock, click here.

More about Imunon

IMUNON is a clinical-stage biotechnology company focused on developing innovative treatments that utilize the body’s natural mechanisms to generate effective responses across various human diseases. The company is advancing its non-viral DNA technology, with its lead clinical program, IMNN-001, targeting advanced ovarian cancer, and has completed multiple clinical trials.

Average Trading Volume: 7,448,895

Technical Sentiment Signal: Hold

Current Market Cap: $20.35M

See more data about IMNN stock on TipRanks’ Stock Analysis page.

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.

Report an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App